共 47 条
- [41] RyR1-targeted drug discovery pipeline integrating FRET-based high-throughput screening and human myofiber dynamic Ca2+ assaysSCIENTIFIC REPORTS, 2020, 10 (01)Rebbeck, Robyn T.论文数: 0 引用数: 0 h-index: 0机构: Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USASingh, Daniel P.论文数: 0 引用数: 0 h-index: 0机构: Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USAJanicek, Kevyn A.论文数: 0 引用数: 0 h-index: 0机构: Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USABers, Donald M.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USAThomas, David D.论文数: 0 引用数: 0 h-index: 0机构: Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USALaunikonis, Bradley S.论文数: 0 引用数: 0 h-index: 0机构: Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USACornea, Razvan L.论文数: 0 引用数: 0 h-index: 0机构: Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA
- [42] High-throughput sequencing of circulating miRNAs in human reveals novel biomarkers for drug-induced liver injury, hepatitis B, liver cirrhosis and type 2 diabetesTOXICOLOGY LETTERS, 2016, 258 : S79 - S79Krauskopf, J.论文数: 0 引用数: 0 h-index: 0机构: Maastricht Univ, Dept Toxicogen, NL-6200 MD Maastricht, Netherlands Maastricht Univ, Dept Toxicogen, NL-6200 MD Maastricht, NetherlandsCaiment, F.论文数: 0 引用数: 0 h-index: 0机构: Maastricht Univ, Dept Toxicogen, NL-6200 MD Maastricht, Netherlands Maastricht Univ, Dept Toxicogen, NL-6200 MD Maastricht, NetherlandsDe Kok, T. M.论文数: 0 引用数: 0 h-index: 0机构: Maastricht Univ, Dept Toxicogen, NL-6200 MD Maastricht, Netherlands Maastricht Univ, Dept Toxicogen, NL-6200 MD Maastricht, NetherlandsJohnson, K. J.论文数: 0 引用数: 0 h-index: 0机构: Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA Maastricht Univ, Dept Toxicogen, NL-6200 MD Maastricht, NetherlandsWarner, R. L.论文数: 0 引用数: 0 h-index: 0机构: Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA Maastricht Univ, Dept Toxicogen, NL-6200 MD Maastricht, NetherlandsSchomaker, S. J.论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Drug Safety Res & Dev, Groton, CT 06340 USA Maastricht Univ, Dept Toxicogen, NL-6200 MD Maastricht, NetherlandsChandler, P.论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Clin Res Unit, New Haven, CT 06510 USA Maastricht Univ, Dept Toxicogen, NL-6200 MD Maastricht, NetherlandsAubrecht, J.论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Drug Safety Res & Dev, Groton, CT 06340 USA Maastricht Univ, Dept Toxicogen, NL-6200 MD Maastricht, NetherlandsKleinjans, J. C.论文数: 0 引用数: 0 h-index: 0机构: Maastricht Univ, Dept Toxicogen, NL-6200 MD Maastricht, Netherlands Maastricht Univ, Dept Toxicogen, NL-6200 MD Maastricht, Netherlands
- [43] The Use of Ratiometric Fluorescence Measurements of the Voltage Sensitive Dye Di-4-ANEPPS to Examine Action Potential Characteristics and Drug Effects on Human Induced Pluripotent Stem Cell-Derived CardiomyocytesTOXICOLOGICAL SCIENCES, 2016, 154 (02) : 320 - 331Hortigon-Vinagre, M. P.论文数: 0 引用数: 0 h-index: 0机构: Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, 126 Univ Pl, Glasgow G12 8TA, Lanark, Scotland Clyde Biosci Ltd, BioCity Scotland, Bo Ness Rd, Newhouse ML1 5UH, Lanark, Scotland Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, 126 Univ Pl, Glasgow G12 8TA, Lanark, Scotland论文数: 引用数: h-index:机构:Burton, F. L.论文数: 0 引用数: 0 h-index: 0机构: Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, 126 Univ Pl, Glasgow G12 8TA, Lanark, Scotland Clyde Biosci Ltd, BioCity Scotland, Bo Ness Rd, Newhouse ML1 5UH, Lanark, Scotland Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, 126 Univ Pl, Glasgow G12 8TA, Lanark, ScotlandGreen, J.论文数: 0 引用数: 0 h-index: 0机构: AbbVie, Dept ZR 13, 1 North Waukegan Rd,Bldg AP-9A, N Chicago, IL 60064 USA Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, 126 Univ Pl, Glasgow G12 8TA, Lanark, ScotlandGintant, G. A.论文数: 0 引用数: 0 h-index: 0机构: AbbVie, Dept ZR 13, 1 North Waukegan Rd,Bldg AP-9A, N Chicago, IL 60064 USA Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, 126 Univ Pl, Glasgow G12 8TA, Lanark, ScotlandSmith, G. L.论文数: 0 引用数: 0 h-index: 0机构: Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, 126 Univ Pl, Glasgow G12 8TA, Lanark, Scotland Clyde Biosci Ltd, BioCity Scotland, Bo Ness Rd, Newhouse ML1 5UH, Lanark, Scotland Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, 126 Univ Pl, Glasgow G12 8TA, Lanark, Scotland
- [44] Profiling cardio-active compound response between high-throughput 2D monolayers, anisotropic and 3-dimensional human induced pluripotent stem cell-derived cardiomyocytesJOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2020, 105Contu, Riccardo论文数: 0 引用数: 0 h-index: 0机构: StemoniX, San Diego, CA USA StemoniX, San Diego, CA USAPadilla, Robert论文数: 0 引用数: 0 h-index: 0机构: StemoniX, San Diego, CA USA StemoniX, San Diego, CA USAFanton, Alison论文数: 0 引用数: 0 h-index: 0机构: StemoniX, San Diego, CA USA StemoniX, San Diego, CA USAVan Hese, Brittney论文数: 0 引用数: 0 h-index: 0机构: StemoniX, San Diego, CA USA StemoniX, San Diego, CA USAAndersen, Carsten论文数: 0 引用数: 0 h-index: 0机构: StemoniX, San Diego, CA USA StemoniX, San Diego, CA USAZanella, Fabian论文数: 0 引用数: 0 h-index: 0机构: StemoniX, San Diego, CA USA StemoniX, San Diego, CA USA
- [45] CSAHi study: Usability assessment of multi-electrode array in combination with human iPS cell-derived cardiomyocytes for prediction of drug-induced QT prolongation and arrhythmia - Multi Channel Systems (MEA60 and MEA2100)JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2016, 81 : 385 - 385Kunimatsua, Takeshi论文数: 0 引用数: 0 h-index: 0机构: Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Osaka, Japan JPMA, Drug Evaluat Comm Nonclin Evaluat Expert Comm, Consortium Safety Assessment Using Human iPS Cell, HEART Team, Tokyo, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Osaka, JapanNozaki, Yumiko论文数: 0 引用数: 0 h-index: 0机构: Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Osaka, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Osaka, JapanHonda, Yayoi论文数: 0 引用数: 0 h-index: 0机构: Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Osaka, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Osaka, JapanWatanabe, Hitoshi论文数: 0 引用数: 0 h-index: 0机构: Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Osaka, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Osaka, JapanYamanishi, Atsuhiro论文数: 0 引用数: 0 h-index: 0机构: JPMA, Drug Evaluat Comm Nonclin Evaluat Expert Comm, Consortium Safety Assessment Using Human iPS Cell, HEART Team, Tokyo, Japan Kyorin Pharmaceut Co Ltd, Toxicol Res Lab, Nogi, Tochigi, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Osaka, JapanNogawa, Hisashi论文数: 0 引用数: 0 h-index: 0机构: Kyorin Pharmaceut Co Ltd, Toxicol Res Lab, Nogi, Tochigi, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Osaka, JapanEndo, Hiroko论文数: 0 引用数: 0 h-index: 0机构: Kyorin Pharmaceut Co Ltd, Toxicol Res Lab, Nogi, Tochigi, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Osaka, JapanSaiki, Shota论文数: 0 引用数: 0 h-index: 0机构: JPMA, Drug Evaluat Comm Nonclin Evaluat Expert Comm, Consortium Safety Assessment Using Human iPS Cell, HEART Team, Tokyo, Japan Shionogi & Co Ltd, Res Lab Dev, Osaka, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Osaka, JapanNagasawa, Chiho论文数: 0 引用数: 0 h-index: 0机构: JPMA, Drug Evaluat Comm Nonclin Evaluat Expert Comm, Consortium Safety Assessment Using Human iPS Cell, HEART Team, Tokyo, Japan Taisho Pharmaceut Co Ltd, Res Ctr, Saitama, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Osaka, JapanNakamori, Chiaki论文数: 0 引用数: 0 h-index: 0机构: Taisho Pharmaceut Co Ltd, Res Ctr, Saitama, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Osaka, JapanNakayama, Chiaki论文数: 0 引用数: 0 h-index: 0机构: Taisho Pharmaceut Co Ltd, Res Ctr, Saitama, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Osaka, JapanIwasaki, Hiroshi论文数: 0 引用数: 0 h-index: 0机构: Taisho Pharmaceut Co Ltd, Res Ctr, Saitama, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Osaka, JapanTakahashi, Etsushi论文数: 0 引用数: 0 h-index: 0机构: JPMA, Drug Evaluat Comm Nonclin Evaluat Expert Comm, Consortium Safety Assessment Using Human iPS Cell, HEART Team, Tokyo, Japan Toyama Chem Co Ltd, Res Labs, Toyama, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Osaka, JapanMiyamoto, Kaori论文数: 0 引用数: 0 h-index: 0机构: Toyama Chem Co Ltd, Res Labs, Toyama, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Osaka, JapanMorimura, Kaoru论文数: 0 引用数: 0 h-index: 0机构: Toyama Chem Co Ltd, Res Labs, Toyama, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Osaka, JapanTanaka, Kohji论文数: 0 引用数: 0 h-index: 0机构: JPMA, Drug Evaluat Comm Nonclin Evaluat Expert Comm, Consortium Safety Assessment Using Human iPS Cell, HEART Team, Tokyo, Japan Nippon Boehringer Ingelheim Co Ltd, Kawanishi, Hyogo, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Osaka, JapanSuzuki, Shinobu论文数: 0 引用数: 0 h-index: 0机构: JPMA, Drug Evaluat Comm Nonclin Evaluat Expert Comm, Consortium Safety Assessment Using Human iPS Cell, HEART Team, Tokyo, Japan Nippon Boehringer Ingelheim Co Ltd, Kawanishi, Hyogo, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Osaka, JapanWashio, Ikumi论文数: 0 引用数: 0 h-index: 0机构: Nippon Boehringer Ingelheim Co Ltd, Kawanishi, Hyogo, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Osaka, Japan
- [46] Development of high-throughput assays for the screening of drug-induced mitotoxicity (Glu/Gal assay) and membrane potential integrity (Mito-ID assay): workflow and software for efficient end-to-end accurate data delivery.TOXICOLOGY LETTERS, 2019, 314 : S191 - S191de Waepenaert, K. G.论文数: 0 引用数: 0 h-index: 0机构: Johnson & Johnson, MIT PDMS D&MS, Beerse, Belgium Johnson & Johnson, MIT PDMS D&MS, Beerse, BelgiumVan Dijck, B.论文数: 0 引用数: 0 h-index: 0机构: Johnson & Johnson, MIT PDMS D&MS, Beerse, Belgium Johnson & Johnson, MIT PDMS D&MS, Beerse, BelgiumPeeters, D.论文数: 0 引用数: 0 h-index: 0机构: Johnson & Johnson, Screening DS, Beerse, Belgium Johnson & Johnson, MIT PDMS D&MS, Beerse, BelgiumMesens, N.论文数: 0 引用数: 0 h-index: 0机构: Johnson & Johnson, MIT PDMS D&MS, Beerse, Belgium Johnson & Johnson, MIT PDMS D&MS, Beerse, Belgium
- [47] CSAHi study-2: Validation of multi-electrode array systems (MEA60/2100) for prediction of drug-induced proarrhythmia using human iPS cell-derived cardiomyocytes: Assessment of reference compounds and comparison with non-clinical studies and clinical informationREGULATORY TOXICOLOGY AND PHARMACOLOGY, 2017, 88 : 238 - 251Nozaki, Yumiko论文数: 0 引用数: 0 h-index: 0机构: Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, JapanHonda, Yayoi论文数: 0 引用数: 0 h-index: 0机构: Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, JapanWatanabe, Hitoshi论文数: 0 引用数: 0 h-index: 0机构: Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, JapanSaiki, Shota论文数: 0 引用数: 0 h-index: 0机构: Shionogi & Co Ltd, Res Lab Dev, 3-1-1 Futaba Cho, Toyonaka, Osaka 5610825, Japan Consortium Safety Assessment Using Human iPS Cell, Toyonaka, Osaka, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, JapanKoyabu, Kiyotaka论文数: 0 引用数: 0 h-index: 0机构: Shionogi & Co Ltd, Res Lab Dev, 3-1-1 Futaba Cho, Toyonaka, Osaka 5610825, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, JapanItoh, Tetsuji论文数: 0 引用数: 0 h-index: 0机构: Shionogi & Co Ltd, Res Lab Dev, 3-1-1 Futaba Cho, Toyonaka, Osaka 5610825, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, JapanNagasawa, Chiho论文数: 0 引用数: 0 h-index: 0机构: Taisho Pharmaceut Co Ltd, Drug Safety, Kita Ku, 1-403 Yoshino Cho, Saitama, Saitama 3319530, Japan Consortium Safety Assessment Using Human iPS Cell, Toyonaka, Osaka, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, JapanNakamori, Chiaki论文数: 0 引用数: 0 h-index: 0机构: Taisho Pharmaceut Co Ltd, Drug Safety, Kita Ku, 1-403 Yoshino Cho, Saitama, Saitama 3319530, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, JapanNakayama, Chiaki论文数: 0 引用数: 0 h-index: 0机构: Taisho Pharmaceut Co Ltd, Drug Safety, Kita Ku, 1-403 Yoshino Cho, Saitama, Saitama 3319530, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, JapanIwasaki, Hiroshi论文数: 0 引用数: 0 h-index: 0机构: Taisho Pharmaceut Co Ltd, Drug Safety, Kita Ku, 1-403 Yoshino Cho, Saitama, Saitama 3319530, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, JapanSuzuki, Shinobu论文数: 0 引用数: 0 h-index: 0机构: Nippon Boehringer Ingelheim Co Ltd, Chuo Ku, 6-7-5 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, JapanTanaka, Kohji论文数: 0 引用数: 0 h-index: 0机构: Nippon Boehringer Ingelheim Co Ltd, Chuo Ku, 6-7-5 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, JapanTakahashi, Etsushi论文数: 0 引用数: 0 h-index: 0机构: Toyama Chem Co Ltd, Res Labs, 4-1,Shimookui 2 Chome, Toyama 9308508, Japan Consortium Safety Assessment Using Human iPS Cell, Toyonaka, Osaka, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, JapanMiyamoto, Kaori论文数: 0 引用数: 0 h-index: 0机构: Toyama Chem Co Ltd, Res Labs, 4-1,Shimookui 2 Chome, Toyama 9308508, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, JapanMorimura, Kaoru论文数: 0 引用数: 0 h-index: 0机构: Toyama Chem Co Ltd, Res Labs, 4-1,Shimookui 2 Chome, Toyama 9308508, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, JapanYamanishi, Atsuhiro论文数: 0 引用数: 0 h-index: 0机构: Kyorin Pharmaceut Co Ltd, Toxicol Res Lab, 1848 Nogi, Nogi, Tochigi 3290114, Japan Consortium Safety Assessment Using Human iPS Cell, Toyonaka, Osaka, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, JapanEndo, Hiroko论文数: 0 引用数: 0 h-index: 0机构: Kyorin Pharmaceut Co Ltd, Toxicol Res Lab, 1848 Nogi, Nogi, Tochigi 3290114, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, JapanShinozaki, Junko论文数: 0 引用数: 0 h-index: 0机构: Kyorin Pharmaceut Co Ltd, Toxicol Res Lab, 1848 Nogi, Nogi, Tochigi 3290114, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, JapanNogawa, Hisashi论文数: 0 引用数: 0 h-index: 0机构: Kyorin Pharmaceut Co Ltd, Toxicol Res Lab, 1848 Nogi, Nogi, Tochigi 3290114, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, JapanShinozawa, Tadahiro论文数: 0 引用数: 0 h-index: 0机构: Takeda Pharmaceut Co Ltd, Drug Safety Res Labs, 26-1,Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, Japan Consortium Safety Assessment Using Human iPS Cell, Toyonaka, Osaka, Japan Japan Pharmaceut Mfg Assoc, Nonclin Evaluat Expert Comm, Drug Evaluat Comm, Tokyo, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, JapanSaito, Fumiyo论文数: 0 引用数: 0 h-index: 0机构: Chem Evaluat & Res Inst Japan CERI, Chem Assessment & Res Ctr, 1600 Shimotakano, Sugito, Saitama 3450043, Japan Consortium Safety Assessment Using Human iPS Cell, Toyonaka, Osaka, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, JapanKunimatsu, Takeshi论文数: 0 引用数: 0 h-index: 0机构: Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, Japan Consortium Safety Assessment Using Human iPS Cell, Toyonaka, Osaka, Japan Japan Pharmaceut Mfg Assoc, Nonclin Evaluat Expert Comm, Drug Evaluat Comm, Tokyo, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, Japan